Programme préliminaire

Shai Izraeli, University of Tel-Aviv, Pediatric Hemato-Oncology, Schneider Children Medical Center, Petach Tiqva, Israel 

A tale of two ETS factors and their roles in leukemogenesis

Isidro Sánchez-García,  Instituto de Biología Molecular y Celular del Cáncer-IBMCC (CSIC-USAL). Salamanca, Spain

A consensus model for the causation of childhood B cell precursor ALL

Elisa Laurenti, Wellcome - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge

Functional and molecular diversity of the human haematopoietic stem cell compartment

Karl Balabanian, Institut Saint-Louis, Université Paris Cité, INSERM U1160, Paris

CXCR4 signaling, a gatekeeper orchestrating the specification of hematopoietic multipotent progenitors and skeletal stromal cells

Simon Haas, Max-Delbrück-Centrum für Molekulare Medizin (MDC), Germany

Single-cell and spatial multi-omics approaches of the hematopoietic system in health and disease

Véronique Maguer Satta, CRCL, Lyon, UMR5286-U1052

 Alteration of the BMP signaling in stem cells and their niche contribute to cancer initiation and could result from environmental pollutant exposure

Nina Cabezas-Wallscheid, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany

Regulation of dormant hematopoietic stem cells

Paul Bourgine, University of Lund, Sweden

Personalized engineering of human hematopoietic niches

Karen Keeshan, Paul O'Gorman Leukaemia Research Centre, Glasgow, Scotland 

Modelling paediatric AML to uncover age-specific mechanisms and therapies

Thomas Mercher, INSERM et Institut Gustave Roussy, Villejuif

Models and molecular mechanisms of childhood megakaryoblastic leukemia

Bérangère de Laval, Centre d’immunologie de Marseille Luminy (CIML), Marseille

Immune response and memory of hematopoietic stem cell.

Delphine Potier, Centre d’immunologie de Marseille Luminy (CIML), Marseille

Using scRNAseq to investigate physiological and pathological development of lymphocytes: from fundamental to clinical applications

Laura Poillet, Centre de recherches en cancérologie de Toulouse (CRCT) Toulouse 

Role of host autophagy in leukemia metabolism and resistance